Colorado Forges Ahead On A New Model For Health Care While Nation Waits

This story also ran on USA Today. This story can be republished for free (details). DENVER — With the nation’s capital mired in gridlock and the Affordable Care Act facing a dire legal challenge, the prospects of lowering health care Read more

read more →

Readers And Tweeters Dive Into Debate Over ‘Medicare For All’

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Savings For All? Your criticism about former Vice President Joe Biden’s “Medicare for All” cost Read more

read more →

KHN’s ‘What The Health?’: Live from D.C. With Rep. Donna Shalala

Can’t see the audio player? Click here to listen on SoundCloud. President Donald Trump’s proposed budget for the fiscal year that begins in October proposes big cuts to popular programs, including Medicaid and the National Institutes of Health. Although those cuts Read more

read more →

In Fierce Debate, Democratic Candidates Expand Health Agenda Arguments

Democratic presidential candidates faced off on the debate stage for the eighth time this campaign season. Meeting in Manchester, N.H., they returned to now familiar health care themes — “Medicare for All” versus a public option, the cost of prescription Read more

read more →

A Guide To Following The Health Debate In The 2020 Elections

About HealthBent KHN’s chief Washington correspondent, Julie Rovner, who has covered health care for more than 30 years, offers insight and analysis of policies and politics in her regular HealthBent columns. Send questions to [email protected] This story also ran on NPR. Read more

read more →

Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers

Doctors fear that the only drug approved to prevent preterm birth, the nation’s leading cause of infant mortality and disability, will no longer be available to expectant mothers. The drug, sold under the brand name Makena, has been in limbo Read more

read more →

Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale

This story also ran on CNN. This story can be republished for free (details). The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a Read more

read more →

Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices

Use Our Content This story can be republished for free (details). It was not the centerpiece, but health was a persistent theme in President Donald Trump’s State of the Union address at the Capitol on Tuesday night. Although the administration Read more

read more →

Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs

Use Our Content This story can be republished for free (details). Senators railed against pharmaceutical executives Tuesday for declining to testify before Congress about out-of-control drug prices, as lawmakers on both sides of the U.S. Capitol kicked off investigations sure Read more

read more →

Must-Reads Of The Week From Brianna Labuskes

The Friday Breeze Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend. Happy Friday! It seems we have a new example of just Read more

read more →